Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer#United_States#Cambridge#Repertoire_Immune#Robert_Andtbacka#TCR_Bispecific
Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer
Repertoire Immune Medicines appoints Dr. Robert Andtbacka as CMO, enhancing leadership as they advance a promising TCR bispecific therapy into clinical trials.
third-news.com
June 4, 2025 at 12:19 PM
Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer#United_States#Cambridge#Repertoire_Immune#Robert_Andtbacka#TCR_Bispecific